Get started
SELVAS HEALTHCARE, INC.SS

SELVAS HEALTHCARE, INC.

4,820KRWD
−160−3.21%
At close at Jun 13, 09:00 GMT
KRW
No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

208370 fundamentals

Key facts

Market capitalization‪123.96 B‬KRW
Dividend yield (indicated)—
Price to earnings Ratio (TTM)47.62
Basic EPS (TTM)104.92KRW
Founded1999
Employees (FY)132
CEOByeong-Tak Yoo
Websiteselvashealthcare.com
About

SELVAS Healthcare, Inc. is a digital healthcare company, which engages in medical device and visual assistance technology. It operates through the Medical Diagnostic Equipment and Assistive Technology Devices business division. The Medical Diagnostic Equipment business division is involved in body composition analyzer and fully automatic blood pressure monitor. The Assistive Technology Devices business division focuses on braille information terminals and reading magnifiers. The company was founded on January 21, 1999 and is headquartered in Daejeon, South Korea.

Ownership
‪‪25.72 M‬‬
Free Float shares
‪‪15.31 M‬‬ (59.52%)
Closely held shares
‪‪10.41 M‬‬ (40.48%)
Free Float shares
‪‪15.31 M‬‬ (59.52%)
Closely held shares
‪‪10.41 M‬‬ (40.48%)
Capital structure
Market cap
‪‪123.96 B‬‬
Debt
‪‪2.69 B‬‬
Cash & equivalents
‪‪22.56 B‬‬
Enterprise value
‪‪104.09 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪123.96 B‬‬
Price to earning ratio (P/E)
47.62x
Price to sales ratio (P/S)
4.00x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
47.62x
Price to sales ratio (P/S)
4.00x
Valuation ratios
‪0.00‬
‪1.30‬
‪2.60‬
‪3.90‬
‪5.20‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪15.00‬
‪30.00‬
‪45.00‬
‪60.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪2%‬
‪8%‬
‪14%‬
‪20%‬
‪26%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪2.50 B‬‬
‪‪5.00 B‬‬
‪‪7.50 B‬‬
‪‪10.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Medical Diagnosis
Assistant Technology
By country
Period: 2024
South Korea
Oceania
Asia
North America
Europe
Other

Dividends

Dividend yield, history and sustainability

No dividends
208370 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−5.00 B‬‬
‪0.00‬
‪‪5.00 B‬‬
‪‪10.00 B‬‬
‪‪15.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪11.00 B‬‬
‪‪22.00 B‬‬
‪‪33.00 B‬‬
‪‪44.00 B‬‬
Assets
Liabilities